Chimin Health Management Co., Ltd. (SHA:603222)

Market Cap	4.65B +31.6%
Revenue (ttm)	637.78M -29.1%
Net Income	-165.28M
EPS	-0.31
Shares Out	523.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,198,560
Average Volume	12,415,494
Open	8.52
Previous Close	8.57
Day's Range	8.52 - 9.00
52-Week Range	5.22 - 15.10
Beta	0.45
RSI	48.40
Earnings Date	Apr 23, 2026

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and o...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 1,994
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603222

Financial Performance

In 2024, Chimin Health Management's revenue was 775.73 million, a decrease of -13.28% compared to the previous year's 894.51 million. Losses were -59.71 million, -8.81% less than in 2023.